Document Detail

Plasminogen activator inhibitor-1 4G allele in the 4G/5G promoter polymorphism increases the occurrence of cerebral ischemia after aneurysmal subarachnoid hemorrhage.
MedLine Citation:
PMID:  15105509     Owner:  NLM     Status:  MEDLINE    
BACKGROUND AND PURPOSE: In several acute life-threatening diseases, the 4G-allele in the 4G/5G-promotor polymorphism in the plasminogen activator inhibitor-1 (PAI-1) gene is associated with higher PAI-1 levels and increased poor outcome, probably by promoting the formation of microthrombi. The aim of the present study was to investigate whether the PAI-1 4G/5G polymorphism is associated with the occurrence of cerebral ischemia, rebleeding, and other events, and clinical outcome after aneurysmal subarachnoid hemorrhage. METHODS: DNA was collected and analyzed in 126 patients with aneurysmal subarachnoid hemorrhage admitted to the Academic Medical Centre Amsterdam and University Medical Centre Utrecht in the Netherlands. All episodes of deterioration were classified according to predefined criteria. Causes of poor outcome and functional outcome were assessed 3 months after the initial bleeding according to the 5-point Glasgow Outcome Scale (GOS). RESULTS: Secondary ischemia occurred more often in patients with the 4G genotype than in patients homozygous for the 5G allele (RR: 3.3; 95% CI: 1.1 to 10.0). No significant differences were found between the groups for rebleeding or other events. Patients with the 4G genotype tended to have a higher risk for poor outcome than patients with the 5G/5G genotype (RR 1.2; 95% CI 0.7 to 2.2). CONCLUSIONS: The 4G allele in the PAI-1 gene increases the risk for cerebral ischemia after aneurysmal subarachnoid hemorrhage (SAH) and probably also the risk for poor outcome. After early aneurysm occlusion, treatment aimed at enhancing fibrinolysis might be effective to prevent and treat cerebral ischemia in patients with aneurysmal SAH.
M D I Vergouwen; C J M Frijns; Y B W E M Roos; G J E Rinkel; F Baas; M Vermeulen
Related Documents :
15030259 - Endo-exuberance and abdominal aortic aneurysm management: have we gone too far?
15483279 - A randomized trial comparing conventional and endovascular repair of abdominal aortic a...
11331829 - Outcome after unilateral hypogastric artery occlusion during endovascular aneurysm repair.
18638739 - Angiographic vasospasm in a contemporary series of patients with aneurysmal subarachnoi...
12925289 - Comparative audit of abdominal aortic aneurysm repairs using possum scores.
15270419 - Incidence and evolution of aortic aneurysm in patients with bladder cancer.
21200229 - Evaluation of terminology for vascular anomalies in current literature.
18534399 - Range of motion of standard and high-flexion cruciate retaining total knee prostheses.
23956299 - Surgery for 'asymptomatic' mild primary hyperparathyroidism improves some clinical symp...
Publication Detail:
Type:  Journal Article     Date:  2004-04-22
Journal Detail:
Title:  Stroke; a journal of cerebral circulation     Volume:  35     ISSN:  1524-4628     ISO Abbreviation:  Stroke     Publication Date:  2004 Jun 
Date Detail:
Created Date:  2004-05-28     Completed Date:  2004-11-16     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  0235266     Medline TA:  Stroke     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1280-3     Citation Subset:  IM    
Department of Neurology, Academic Medical Center, Amsterdam, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Brain Ischemia / diagnosis,  epidemiology,  genetics*
Intracranial Aneurysm / complications
Middle Aged
Plasminogen Activator Inhibitor 1 / genetics*
Polymorphism, Genetic*
Promoter Regions, Genetic
Subarachnoid Hemorrhage / complications*,  diagnosis,  etiology
Reg. No./Substance:
0/Plasminogen Activator Inhibitor 1

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA):...
Next Document:  Topiramate extends the therapeutic window for hypothermia-mediated neuroprotection after stroke in n...